Vivera Pharmaceuticals is actively seeking qualified licensing, clinical research and distribution partners worldwide.

With an exclusive global license of the patented and one-of-a-kind sublingual drug-delivery system, TABMELT, Vivera is looking for partners to sublicense this unique technology.

Vivera's goal is to gain FDA approval for its products through the Investigational New Drug (IND) and New Drug Application (NDA) process to globally commercialize its finished pharmaceutical products.

To learn more about licensing and partnership opportunities please contact info@viverapharma.com.